A carregar...
Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer
ER positive (ER+) and HER2 negative (HER2-) breast cancers are routinely treated based on estrogen dependence. CDK4/6 inhibitors in combination with endocrine therapy have significantly improved the progression-free survival of patients with ER+/HER2- metastatic breast cancer. Gene expression profil...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342463/ https://ncbi.nlm.nih.gov/pubmed/27564114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11588 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|